The healthcare sector is continually exploring innovative therapies for chronic diseases. Among these breakthroughs, FDA-Registered Peptides have emerged as a potential approach. , Particularly Apis, Liraglutide, https://iwangele441646.loginblogin.com/44298442/fda-approved-peptides-apis-liraglutide-tirzepatide-semaglutide